List of Nodal Officer
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Complete List of Books in Library Acc No Author Title of Book Subject Publisher Year R.No
Complete List of Books in Library Acc No Author Title of book Subject Publisher Year R.No. 1 Satkari Mookerjee The Jaina Philosophy of PHIL Bharat Jaina Parisat 8/A1 Non-Absolutism 3 Swami Nikilananda Ramakrishna PER/BIO Rider & Co. 17/B2 4 Selwyn Gurney Champion Readings From World ECO `Watts & Co., London 14/B2 & Dorothy Short Religion 6 Bhupendra Datta Swami Vivekananda PER/BIO Nababharat Pub., 17/A3 Calcutta 7 H.D. Lewis The Principal Upanisads PHIL George Allen & Unwin 8/A1 14 Jawaherlal Nehru Buddhist Texts PHIL Bruno Cassirer 8/A1 15 Bhagwat Saran Women In Rgveda PHIL Nada Kishore & Bros., 8/A1 Benares. 15 Bhagwat Saran Upadhya Women in Rgveda LIT 9/B1 16 A.P. Karmarkar The Religions of India PHIL Mira Publishing Lonavla 8/A1 House 17 Shri Krishna Menon Atma-Darshan PHIL Sri Vidya Samiti 8/A1 Atmananda 20 Henri de Lubac S.J. Aspects of Budhism PHIL sheed & ward 8/A1 21 J.M. Sanyal The Shrimad Bhagabatam PHIL Dhirendra Nath Bose 8/A2 22 J.M. Sanyal The Shrimad PHIL Oriental Pub. 8/A2 Bhagabatam VolI 23 J.M. Sanyal The Shrimad PHIL Oriental Pub. 8/A2 Bhagabatam Vo.l III 24 J.M. Sanyal The Shrimad Bhagabatam PHIL Oriental Pub. 8/A2 25 J.M. Sanyal The Shrimad PHIL Oriental Pub. 8/A2 Bhagabatam Vol.V 26 Mahadev Desai The Gospel of Selfless G/REL Navijvan Press 14/B2 Action 28 Shankar Shankar's Children Art FIC/NOV Yamuna Shankar 2/A2 Number Volume 28 29 Nil The Adyar Library Bulletin LIT The Adyar Library and 9/B2 Research Centre 30 Fraser & Edwards Life And Teaching of PER/BIO Christian Literature 17/A3 Tukaram Society for India 40 Monier Williams Hinduism PHIL Susil Gupta (India) Ltd. -
Download Full Report
CONTENTS 02 Unstoppable Corporate overview We have been persistent 02 Unstoppable in our aim to establishing 04 Chairman’s Message and maintaining market leadership to be able to achieve 06 Vice Chairman’s Message unprecedented growth for our 08 Board of Directors stakeholders. 10 Management Board 12 Key Performance Highlights 14 14 Integrated Report Integrated Report 28 Management Discussion & Analysis Apollo Tyres’ contribution 51 Sustainability Snapshot to social and economic development is critical to create and sustain an enabling environment for investment. This has enabled the Company’s positioning as a credible Statutory Reports stakeholder partner. 84 Board’s Report 95 Annual Report on CSR 28 102 Business Responsibility Report Management 126 Corporate Governance Report Discussion & Analysis Financial Statements 161 Standalone Financial Statements 223 Consolidated Financial Statements UNSTOPPABLE Since inception, we have worked towards establishing ourselves as a leading player in the sale and manufacture of tyres. We have been persistent in our aim to establishing and maintaining market leadership and be able to achieve unprecedented growth for our stakeholders. In FY2018-19 (FY2019), we continued to focus We are unstoppable in establishing our on our key revenue generating regions APMEA leadership across multiple segments. (Asia Pacific, Middle East and Africa, including Our consistently advancing product range coupled India) and Europe. We expanded our presence in with product innovations are enabling us to achieve Americas by added new territories and increasing the same. our value proposition. The APMEA operation continued its focus on consolidating its leadership We are unstoppable in working towards achieving and enhancing share in India through the cutting edge manufacturing capabilities and introduction of best in class and technologically world-class R&D. -
Automobile Industry Updates
India Automobile Industry Updates In this issue: Automobile Industry Updates Effect of Recession GM Files For Bankruptcy Issue No 3 Shifts reduced at Bridgestone factory. May 2009 Press Release Effects of Recession Car Exports Up 42% in May Nashik strike a setback for GM Files for Bankruptcy Mahindra's Xylo It was once an icon for industry. Monday, General Motors became the largest Nashik strike causes production losses of Rs manufacturing company in U.S. history and fourth largest company ever to file for 150 crore to Mahindra's bankruptcy protection. vendors Senior administration officials said the government will provide $30 billion in financing Tata, M&M, Maruti join hands for hybrid models to help the automaker through bankruptcy. Those same officials said the Canadian government would provide $9.5 billion. Global car cos to take Maruti's route JLR to get 'conditional' More support only: UK Govt Shifts reduced at Bridgestone factory Audi aims 55 pc growth this fiscal from India Bridgestone has cut three production shifts at its Salisbury factory as demand slumps Ashok Leyland, Nissan for its truck and trailer tyres. The company told workers this week it needed to reduce venture delayed 6 months inventory levels to match sales, which have fallen during the economic downturn. UK Govt-JLR talks back on Workers will be given other duties during the seven-week hiatus, which will cut truck track and bus tyre production by 20 hours a week. TVS can make, sell original Flame: HC More Tata Motors plans Rs 4,200 cr debenture issue: Crisil Press Release Ford to Make India Export Hub for Small Cars Car Exports Up 42% in May Exports of passenger cars from the country soared 41.64 per cent in May, mainly on Natural rubber imports might double the back of robust performance by Maruti Suzuki, although domestic sales increased by a meager 2.48 per cent. -
SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI Trading As ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP
Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI trading as ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP. COTTON GREEN RLY. STN. MUMBAI-400033. MANUFACTURE & MERCHANT INDIAN NATIONAL Used Since :31/01/2001 MUMBAI MEDICINAL PREPARATIONS. 537 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SEPTIGARD 1741718 08/10/2008 INDERJIT SINGH trading as ;INDERJIT SINGH B-104 , SWASTHYA SINGH , NEW DELHI -92 MERCHANTS & MANUFACTUERERS Address for service in India/Agents address: MAHTTA & CO. 43 - B/3, MAHTTA HOUSE,UDHAM SINGH NAGAR, LUDHIANA - 141 001, (PUNJAB). Proposed to be Used DELHI MEDICINAL & PHARMACEUTICAL PREPARATIONS. 538 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 FAIR & BEAUTY 1803779 08/04/2009 GALPHA LABORATORIES LIMITED 221, Kanakia Zillion, E Wing Bandra Kurla Complex Annex LBS Marg & CST Road Junction Kurla West MUMBAI 400070 MANUFACTURERS AND MERCHANTS INDIAN NATIONAL Used Since :15/11/2007 MUMBAI PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES 539 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 O-BAMA 1815900 08/05/2009 KREMOINT PHARMA PVT. LTD. 151/5, SHRI KRISHNA DARSHAN, GARODIA NAGAR, GHATKOPAR (E), BOMBAY-400 077. MANUFACTURERS AND MERCHANTS. A CORPORATE ENTITY INCORPORATED IN INDIA UNDER THE COMPANIES ACT 1956. Address for service in India/Attorney address: KRISLAW CONSULTANTS BUILDING NO.4, C/104, SHANKESHWAR PALMS, BEHIND MODEL SCHOOL, KUMBHARKHANPADA, SUBHASH ROAD, DOMBIVILI(W) 421202 Used Since :02/05/2009 MUMBAI PHARMACETICAL AND MEDICINAL PREPARATIONS. 540 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 AYUSHAKTI D-VYRO 1815928 08/05/2009 SMITA NARAM BUNGALOW NO.31, NEXT TO M. -
Reg. No Name in Full Residential Address Gender Contact No
Reg. No Name in Full Residential Address Gender Contact No. Email id Remarks 20001 MUDKONDWAR SHRUTIKA HOSPITAL, TAHSIL Male 9420020369 [email protected] RENEWAL UP TO 26/04/2018 PRASHANT NAMDEORAO OFFICE ROAD, AT/P/TAL- GEORAI, 431127 BEED Maharashtra 20002 RADHIKA BABURAJ FLAT NO.10-E, ABAD MAINE Female 9886745848 / [email protected] RENEWAL UP TO 26/04/2018 PLAZA OPP.CMFRI, MARINE 8281300696 DRIVE, KOCHI, KERALA 682018 Kerela 20003 KULKARNI VAISHALI HARISH CHANDRA RESEARCH Female 0532 2274022 / [email protected] RENEWAL UP TO 26/04/2018 MADHUKAR INSTITUTE, CHHATNAG ROAD, 8874709114 JHUSI, ALLAHABAD 211019 ALLAHABAD Uttar Pradesh 20004 BICHU VAISHALI 6, KOLABA HOUSE, BPT OFFICENT Female 022 22182011 / NOT RENEW SHRIRANG QUARTERS, DUMYANE RD., 9819791683 COLABA 400005 MUMBAI Maharashtra 20005 DOSHI DOLLY MAHENDRA 7-A, PUTLIBAI BHAVAN, ZAVER Female 9892399719 [email protected] RENEWAL UP TO 26/04/2018 ROAD, MULUND (W) 400080 MUMBAI Maharashtra 20006 PRABHU SAYALI GAJANAN F1,CHINTAMANI PLAZA, KUDAL Female 02362 223223 / [email protected] RENEWAL UP TO 26/04/2018 OPP POLICE STATION,MAIN ROAD 9422434365 KUDAL 416520 SINDHUDURG Maharashtra 20007 RUKADIKAR WAHEEDA 385/B, ALISHAN BUILDING, Female 9890346988 DR.NAUSHAD.INAMDAR@GMA RENEWAL UP TO 26/04/2018 BABASAHEB MHAISAL VES, PANCHIL NAGAR, IL.COM MEHDHE PLOT- 13, MIRAJ 416410 SANGLI Maharashtra 20008 GHORPADE TEJAL A-7 / A-8, SHIVSHAKTI APT., Male 02312650525 / NOT RENEW CHANDRAHAS GIANT HOUSE, SARLAKSHAN 9226377667 PARK KOLHAPUR Maharashtra 20009 JAIN MAMTA -
C:\Users\ACCER\Desktop\JULY QUESTION LIST\Final Make\Final
LOK SABHA ______ List of Questions for ORAL ANSWERS Wednesday, August 11, 2021/Sravana 20, 1943 (Saka) ______ (Prime Minister; Ministries of Atomic Energy; Coal; Commerce and Industry; Communications; Defence; Development of North Eastern Region; Electronics and Information Technology; External Affairs; Law and Justice; Mines; Parliamentary Affairs; Personnel, Public Grievances and Pensions; Planning; Railways; Space; Statistics and Programme Implementation) (¯ÖϬÖÖ®Ö ´ÖÓ¡Öß; ¯Ö¸ü´ÖÖÞÖã ‰ú•ÖÖÔ; ÛúÖêµÖ»ÖÖ; ¾ÖÖ×ÞÖ•µÖ †Öî¸ü ˆªÖêÝÖ; ÃÖÓ“ÖÖ¸ü; ¸üõÖÖ; ˆ¢Ö¸ü ¯Öæ¾Öá õÖê¡Ö ×¾ÖÛúÖÃÖ; ‡»ÖꌙÒüÖò×®ÖÛúß †Öî¸ü ÃÖæ“Ö®ÖÖ ¯ÖÏÖîªÖê×ÝÖÛúß; ×¾Ö¤êü¿Ö; ×¾Ö×¬Ö †Öî¸ü ®µÖÖµÖ; ÜÖÖ®Ö; ÃÖÓÃÖ¤üßµÖ ÛúÖµÖÔ; ÛúÖÙ´ÖÛú, »ÖÖêÛú ׿ÖÛúÖµÖŸÖ †Öî¸ü ¯Öë¿Ö®Ö; µÖÖê•Ö®ÖÖ; ¸êü»Ö; †ÓŸÖ׸üõÖ; ÃÖÖÓ×ܵÖÛúß †Öî¸ü ÛúÖµÖÔÛÎú´Ö ÛúÖµÖÖÔ®¾ÖµÖ®Ö ´ÖÓ¡ÖÖ»ÖµÖ) ______ Total Number of Questions — 20 VIP References authority empowered to act against companies *321. SHRIMATI SANGEETA KUMARI SINGH following unethical business models and infringing on DEO: the Foreign Direct Investment (FDI) norms in the country, SHRI BHOLA SINGH: particularly in e-commerce sector and if so, the details thereof; Will the Minister of RAILWAYS ¸êü»Ö ´ÖÓ¡Öß (b) whether the Government proposes to set up a be pleased to state: regulatory authority for the e-commerce sector in the (a) whether VIP references for release of HO quota country and if so, the details thereof; by the Ministry of Railways/Indian Railways/Zones are (c) whether the Government proposes to not being given priority in recent times; bring in a national -
SNO APP.No Name Contact Address Reason 1 AP-1 K
SNO APP.No Name Contact Address Reason 1 AP-1 K. Pandeeswaran No.2/545, Then Colony, Vilampatti Post, Intercaste Marriage certificate not enclosed Sivakasi, Virudhunagar – 626 124 2 AP-2 P. Karthigai Selvi No.2/545, Then Colony, Vilampatti Post, Only one ID proof attached. Sivakasi, Virudhunagar – 626 124 3 AP-8 N. Esakkiappan No.37/45E, Nandhagopalapuram, Above age Thoothukudi – 628 002. 4 AP-25 M. Dinesh No.4/133, Kothamalai Road,Vadaku Only one ID proof attached. Street,Vadugam Post,Rasipuram Taluk, Namakkal – 637 407. 5 AP-26 K. Venkatesh No.4/47, Kettupatti, Only one ID proof attached. Dokkupodhanahalli, Dharmapuri – 636 807. 6 AP-28 P. Manipandi 1stStreet, 24thWard, Self attestation not found in the enclosures Sivaji Nagar, and photo Theni – 625 531. 7 AP-49 K. Sobanbabu No.10/4, T.K.Garden, 3rdStreet, Korukkupet, Self attestation not found in the enclosures Chennai – 600 021. and photo 8 AP-58 S. Barkavi No.168, Sivaji Nagar, Veerampattinam, Community Certificate Wrongly enclosed Pondicherry – 605 007. 9 AP-60 V.A.Kishor Kumar No.19, Thilagar nagar, Ist st, Kaladipet, Only one ID proof attached. Thiruvottiyur, Chennai -600 019 10 AP-61 D.Anbalagan No.8/171, Church Street, Only one ID proof attached. Komathimuthupuram Post, Panaiyoor(via) Changarankovil Taluk, Tirunelveli, 627 761. 11 AP-64 S. Arun kannan No. 15D, Poonga Nagar, Kaladipet, Only one ID proof attached. Thiruvottiyur, Ch – 600 019 12 AP-69 K. Lavanya Priyadharshini No, 35, A Block, Nochi Nagar, Mylapore, Only one ID proof attached. Chennai – 600 004 13 AP-70 G. -
IN the BUSINESS of PROGRESS CONTENTS Apollo Tyres in Brief
Annual Report 2019-20 IN THE BUSINESS OF PROGRESS CONTENTS Apollo Tyres in brief 01-03 Apollo Tyres is one of the most trusted Corporate factsheet names in the manufacture and sale of tyres. The Company was founded in 1972 and is 04-13 headquartered in Gurugram, Haryana (India). Leadership and governance 06 Chairman’s message 08 Vice-Chairman’s message 10 Board of Directors Catering to all tyre segments 12 Management Team TRUCK AND BUS LIGHT TRUCK 14-77 Performance and progress 16 Key performance indicators 18 Know our capitals 20 Business model 22 Capital-wise information 36 Progress amidst volatility 38 Progress that is sustainable 40 Progress through people centricity 42 Value created for the stakeholders PASSENGER VEHICLES TWO-WHEELER 78-93 Management Discussion & Analysis 94-170 Statutory Reports 94 Board’s Report 107 Annual Report on CSR 113 Business Responsibility Report 138 Corporate Governance Report OFF-HIGHWAY 171-305 Financial Statements 171 Standalone 233 Consolidated Apollo Tyres’ success as a leading tyre such as: geo-political relations, economic manufacturer is inextricably linked with the growth, industry cyclicality, environmental progress of the people, the businesses we issues, technological innovation, safety and partner and the planet at large. We have consumer attitudes. Our FY20 performance is always persevered to exceed expectations, a reflection of the resulting uncertainties. It set new benchmarks and in some cases, is also a testament to our foundational values shape the future of the industry. and intrinsic strengths that have helped us navigate through these uncertainties. Our marquee brands, Apollo and Vredestein, enjoy premium positions in the commercial As we step into a new decade, replete with and passenger vehicle tyre segments in unexplored opportunities, we are keen on India and Europe, respectively. -
Tamil Nadu Government Gazette
© [Regd. No. TN/CCN/467/2012-14. GOVERNMENT OF TAMIL NADU [R. Dis. No. 197/2009. 2017 [Price: Rs. 23.20 Paise. TAMIL NADU GOVERNMENT GAZETTE PUBLISHED BY AUTHORITY No. 21] CHENNAI, WEDNESDAY, MAY 24, 2017 Vaikasi 10, Hevilambi, Thiruvalluvar Aandu – 2048 Part VI—Section 4 Advertisements by private individuals and private institutions CONTENTS PRIVATE ADVERTISEMENTS Pages. Change of Names .. 1127-1182 Notice .. 1182-1183 Notice .. 682-685 NOTICE NO LEGAL RESPONSIBILITY IS ACCEPTED FOR THE PUBLICATION OF ADVERTISEMENTS REGARDING CHANGE OF NAME IN THE TAMIL NADU GOVERNMENT GAZETTE. PERSONS NOTIFYING THE CHANGES WILL REMAIN SOLELY RESPONSIBLE FOR THE LEGAL CONSEQUENCES AND ALSO FOR ANY OTHER MISREPRESENTATION, ETC. (By Order) Director of Stationery and Printing. CHANGE OF NAMES 15990. I, Jeslin Sophia, daughter of Thiru J. Marshal Mohan, 15993. My son, R. Nallathampi, born on 18th October 2016 born on 19th November 1995 (native district: Pudukkottai), (native district: Madurai), residing at No. 12/50, Subramaniya residing at No. 3-379, Subhashini Nagar, Surveyor Siva Street, Sivagiri, Tirunelveli-627 757, shall henceforth be Colony, K. Pudur, Madurai-625 007, shall henceforth be known as R. DHARNEESWARAN known as JESHLIN SOPHIA K. RADHA JESLIN SOPHIA Tirunelveli, 15th May 2017. (Father) Madurai, 15th May 2017. 15994. I, Kannan, son of Thiru K. Muthaiah, 15991. I, S. Murugesan, son of Thiru M. Subbaiah, born on 24th April 1975 (native district: Madurai), born on 20th May 1964 (native district: Tirunelveli), residing residing at No. 2-129, East Street, Ayyangkottai, at No. 2/759-2, G.R. Nagar, 5th Street, Kannanendal Vadipatti Taluk, Madurai-625 221, shall henceforth be K. -
Ajanta Pharma Limited
AJANTA PHARMA LIMITED CIN : L24230MH1979PLC022059 Registered & Corporate Office: ‘Ajanta House’, 98 Govt Industrial Area, Charkop, Kandivli (West), Mumbai - 400 067, Maharashtra, India Tel.: +91 22 6606 1000, Fax: +91 22 6606 1200 | E-mail: [email protected] | Website: www.ajantapharma.com POST BUYBACK PUBLIC ANNOUNCEMENT FOR THE ATTENTION OF EQUITY SHAREHOLDERS/ BENEFICIAL OWNERS OF EQUITY SHARES OF AJANTA PHARMA LIMITED This public announcement (the “Post Buyback Public Announcement”) is being made pursuant to the provisions of Regulation 24(vi) of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, for the time being in force including any statutory modifications and amendments from time to time (the “Buyback Regulations”). This Post Buyback Public Announcement should be read in conjunction with the Public Announcement dated November 4, 2020 which was published on November 5, 2020 (the “Public Announcement”) and the letter of offer dated November 25, 2020 (the “Letter of Offer”) issued in connection with the Buyback. The terms used but not defined in this Post Buyback Public Announcement shall have the same meanings as assigned in the Public Announcement and the Letter of Offer. 1. THE BUYBACK 1.1 Ajanta Pharma Limited (the “Company”) had announced the Buyback of not exceeding 7,35,000 (Seven Lakh Thirty Five Thousand) fully paid-up equity shares of face value of ₹2 each (“Equity Shares”) from all the existing shareholders / beneficial owners of Equity Shares as on the record date (i.e. Friday, November 13, 2020), on a proportionate basis, through the “Tender Offer” process at a price of ₹1,850/- (Rupees One Thousand Eight Hundred and Fifty Only) per Equity Share payable in cash for an aggregate consideration not exceeding ₹ 135,97,50,000 (Rupees One Hundred Thirty Five Crores Ninety Seven Lakhs and Fifty Thousand only) excluding the Transaction Costs (“Buyback Offer Size”). -
Inner 25 India Pharma & Healthcare Fund
Modera erate tely Mod High to e H w at ig o er h L d o M V e r y w H Tata India Pharma & Healthcare Fund o i L g (An open ended equity scheme investing in Pharma and Healthcare Services Sector) h Riskometer Investors understand that their principal As on 30th June 2021 PORTFOLIO will be at Very High Risk INVESTMENT STYLE Company name No. of Market Value % of Company name No. of Market Value % of Primarily focuses on investment in at least 80% of its net Shares Rs. Lakhs Assets Shares Rs. Lakhs Assets assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India. Equity & Equity Related Total 55184.24 97.88 Glenmark Pharmaceuticals Ltd. 167000 1089.76 1.93 INVESTMENT OBJECTIVE Healthcare Services Sanofi India Ltd. 13000 997.39 1.77 The investment objective of the scheme is to seek long Apollo Hospitals Enterprise Ltd. 70500 2551.99 4.53 Gland Pharma Ltd. 19662 673.29 1.19 term capital appreciation by investing atleast 80% of its Fortis Healthcare Ltd. 795000 1935.03 3.43 Laurus Labs Ltd. 90000 619.79 1.10 net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in Syngene International Ltd. 265000 1545.75 2.74 India.However, there is no assurance or guarantee that the investment objective of the Scheme will be Narayana Hrudayalaya Ltd. 301420 1483.74 2.63 Other Equities^ 1186.14 2.10 achieved.The Scheme does not assure or guarantee any Metropolis Healthcare Ltd. -
Thursday, July 11, 2019 / Ashadha 20, 1941 (Saka) ______
LOK SABHA ___ SYNOPSIS OF DEBATES* (Proceedings other than Questions & Answers) ______ Thursday, July 11, 2019 / Ashadha 20, 1941 (Saka) ______ SUBMISSION BY MEMBERS Re: Farmers facing severe distress in Kerala. THE MINISTER OF DEFENCE (SHRI RAJ NATH SINGH) responding to the issue raised by several hon. Members, said: It is not that the farmers have been pushed to the pitiable condition over the past four to five years alone. The miserable condition of the farmers is largely attributed to those who have been in power for long. I, however, want to place on record that our Government has been making every effort to double the farmers' income. We have enhanced the Minimum Support Price and did take a decision to provide an amount of Rs.6000/- to each and every farmer under Kisan Maan Dhan Yojana irrespective of the parcel of land under his possession and have brought it into force. This * Hon. Members may kindly let us know immediately the choice of language (Hindi or English) for obtaining Synopsis of Lok Sabha Debates. initiative has led to increase in farmers' income by 20 to 25 per cent. The incidence of farmers' suicide has come down during the last five years. _____ *MATTERS UNDER RULE 377 1. SHRI JUGAL KISHORE SHARMA laid a statement regarding need to establish Kendriya Vidyalayas in Jammu parliamentary constituency, J&K. 2. DR. SANJAY JAISWAL laid a statement regarding need to set up extension centre of Mahatma Gandhi Central University, Motihari (Bihar) at Bettiah in West Champaran district of the State. 3. SHRI JAGDAMBIKA PAL laid a statement regarding need to include Bhojpuri language in Eighth Schedule to the Constitution.